Create a Report

Please provide report title
Please provide location
Please provide details

Add more

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Drop files here
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!

Your report is queued!

It may take up to 12 hours to process your report.

Email us at support@safelyhq.com if you have questions.

Safety Report: MegMan Performance Booster capsules - recalled due to undeclared Tadalafil, USA

3 years ago source fda.gov

Recall notice

United States

Junp LLC is voluntarily recalling Lot number 2010291, Exp Date: 01/07/2024 of MegMan Performance Booster capsules, packaged in 10-count blisters packaged in a carton to the consumer level. Junp LLC was notified by Amazon that laboratory analysis has found the product to be tainted with Tadalafil.

Tadalafil is an ingredient in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. The presence of tadalafil in MegMan Performance Booster makes this product an unapproved drug for which the safety and efficacy has not been established and therefore, subject to recall. Consumers with underlying medical issues who take MegMan Performance Booster Capsules with undeclared tadalafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, Junp LLC has not received any reports of adverse events related to this recall.

The product is marketed as a dietary supplement for male sexual enhancement and is packaged in 10 count blisters packaged in a carton, UPC 8 48998 0091 2. The affected lot number of MegMan performance booster include Lot # 2010291, Exp Date 01/07/2024.

MegMan Performance Booster was distributed via internet and fulfilled by Amazon from 11/10/2021 till 12/27/2021 at www.amazon.com nationwide in the USA. On December 17, 2022, FDA issued a press release that warned consumers to avoid certain products founds on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encourages online marketplaces to ensure these products are not sold on their platforms.

Junp LLC is notifying its distributors and customers by Amazon Messaging and is arranging return of all recalled products. Consumers that have MegMan Performance Booster which is being recalled should stop using the product. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. FDA Press Release  

Check the full recall details on www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/junp-llc-issues-voluntary-nationwide-recall-megman-performance-booster-capsules-due-presence

Source: FDA

#drugs #amazon #recall #blood #unitedstates

Recent Reports Near Me